biotin has been researched along with Bladder Cancer in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (40.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collares, T; da Silva, FD; Dornelles, L; Dos Santos, ACF; Garcia, FD; Leitemberger, A; Nogara, PA; Oliveira, CS; Piccoli, BC; Rocha, JBT; Rodrigues, OED; Schachtschneider, KM; Seixas, FK; Sonego, MS | 1 |
| Ouyang, J; Sun, F; Zhang, L; Zhao, W | 1 |
| An, Y; Chen, K; He, J; He, Z; Jiang, K; Sun, F; Tang, L; Zhang, X | 1 |
| Chen, Q; Chen, X; Dong, L; Gao, J; Hu, Z; Li, J; Xu, X; Zhang, X; Zhang, Z | 1 |
| Omran, OM | 1 |
| Bartolomei, M; Chinol, M; De Cobelli, O; Matei, DV; Paganelli, G; Papi, S; Scardino, E; Trifirò, G; Verweij, F | 1 |
| Davis, DW; Dinney, CP; Eve, BY; Huang, S; Kamat, A; Kedar, D; Mohamedali, KA; Rosenblum, MG; Sweeney, P; Thorpe, PE | 1 |
| Bouchier-Hayes, D; Ciznadija, D; Elwood, NJ; Gibbs, P; Gras, E; Neylon, CB; Nice, EC; Ramsay, RG; Rosenthal, MA; Rothacker, J | 1 |
| Fujime, M; Kirley, SD; Lin, CW; Prout, GR | 1 |
| Javadpour, N; McAlpine, RG; O'Connell, KJ; Vafier, JA; Worsham, GF | 1 |
| De Fazio, SR; Gozzo, JJ; Monaco, AP | 1 |
| Sasaki, K | 1 |
| Alexander, CJ; Calaluce, RD; Loy, TS | 1 |
| Carrasco-Aznar, JC; Escudero, AL; López-Beltrán, A; Vicioso-Recio, L | 1 |
| Baume, H; Dietel, M; Kaufmann, O | 1 |
| Chiang, C; Huang, CH; Lin, LM; Tan, LB | 1 |
| Kakizoe, T; Niijima, T; Sato, S; Sekine, T; Takai, K | 1 |
| Gosden, JR; Porteous, DJ | 1 |
| Benson, RW; Flammang, TJ; Kudlubar, FF; Roberts, DW | 1 |
| deKernion, JB; Lovrekovich, L; Studer, UE | 1 |
20 other study(ies) available for biotin and Bladder Cancer
| Article | Year |
|---|---|
Synthesis and biological evaluation of new antioxidant and antiproliferative chalcogenobiotin derivatives for bladder carcinoma treatment.
Topics: Antineoplastic Agents; Antioxidants; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Chalcogens; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lipid Peroxidation; Molecular Structure; Picrates; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neoplasms | 2020 |
NEAT1 variant 1 weakens the genome-wide effect of miR-3122 on blocking H3K79me3 in bladder cancer.
Topics: Apoptosis; Biotin; Cell Proliferation; Gene Expression Regulation, Neoplastic; Histones; Humans; MicroRNAs; RNA, Long Noncoding; Urinary Bladder Neoplasms | 2022 |
BSA modification of bacterial surface: a promising anti-cancer therapeutic strategy.
Topics: Bacteria; Biotin; Escherichia coli; Humans; Serum Albumin, Bovine; Urinary Bladder Neoplasms | 2023 |
The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer.
Topics: Administration, Intravesical; Animals; Biotin; CD40 Ligand; Cell Line, Tumor; Female; Immobilized Proteins; Immunotherapy; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Recombinant Fusion Proteins; Streptavidin; Urinary Bladder Neoplasms | 2011 |
CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Biotin; Cadherins; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Disease Progression; Egypt; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Neprilysin; Schistosomiasis; Streptavidin; Stromal Cells; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2012 |
Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy.
Topics: Aged; Aged, 80 and over; Avidin; Biotin; Female; Humans; Male; Middle Aged; Pilot Projects; Radionuclide Imaging; Technetium Compounds; Urinary Bladder Neoplasms | 2003 |
The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.
Topics: Animals; Biotin; Blotting, Western; Cell Line, Tumor; Coculture Techniques; Dose-Response Relationship, Drug; Endothelium, Vascular; Gels; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Swine; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A | 2005 |
A novel magnetic bead-based assay with high sensitivity and selectivity for analysis of telomerase in exfoliated cells from patients with bladder and colon cancer.
Topics: Bacterial Proteins; Biomarkers, Tumor; Biosensing Techniques; Biotin; Colonic Neoplasms; Feces; Horseradish Peroxidase; Humans; Immunomagnetic Separation; Luminescent Measurements; Neoplasm Proteins; Oligonucleotide Probes; Reference Standards; Sensitivity and Specificity; Staining and Labeling; Telomerase; Uracil Nucleotides; Urinary Bladder Neoplasms; Urine | 2007 |
Visualization of urothelial blood group isoantigens A and B using direct biotin-labeled antibodies and avidin-biotin-peroxidase complex.
Topics: ABO Blood-Group System; Avidin; Biotin; Carcinoma, Transitional Cell; Epithelial Cells; Epithelium; Epitopes; Histological Techniques; Humans; Isoantigens; Peroxidases; Ureter; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
Avidin-biotin technique is more sensitive than lectin assay for detecting the Thomsen-Friedenreich antigen (T-antigen) in transitional cell carcinoma of the bladder.
Topics: Antigens, Tumor-Associated, Carbohydrate; Avidin; Biotin; Carcinoma, Transitional Cell; False Negative Reactions; Histocytochemistry; Humans; Immunoenzyme Techniques; Lectins; Urinary Bladder Neoplasms | 1984 |
An enzyme immunoassay for urinary C-reactive protein.
Topics: Binding Sites, Antibody; Binding, Competitive; Biotin; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Humans; Hydrogen-Ion Concentration; Immunodiffusion; Immunoenzyme Techniques; Reference Values; Temperature; Time Factors; Urinary Bladder Neoplasms | 1983 |
[The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
Topics: ABO Blood-Group System; Antigens, Tumor-Associated, Carbohydrate; Avidin; Biotin; Carcinoma; Carcinoma in Situ; Disaccharides; Erythrocytes; Humans; Immune Adherence Reaction; Peroxidases; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 1984 |
Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma.
Topics: Antibodies, Monoclonal; Antibody Specificity; Avidin; Biomarkers, Tumor; Biotin; Carcinoma, Transitional Cell; Diagnosis, Differential; Epithelium; Humans; Immunohistochemistry; Lewis X Antigen; Retrospective Studies; Urinary Bladder; Urinary Bladder Neoplasms | 1995 |
Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization.
Topics: Aged; Aged, 80 and over; Biotin; Capsid; Carcinoma, Transitional Cell; DNA Probes, HPV; Female; Humans; Immunohistochemistry; In Situ Hybridization; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Urinary Bladder Neoplasms | 1996 |
Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique.
Topics: Adult; Aged; Aged, 80 and over; Biotin; Carcinoma, Transitional Cell; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Invasiveness; Receptors, Estrogen; Retrospective Studies; Tyramine; Urinary Bladder Neoplasms | 1998 |
Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
Topics: ABO Blood-Group System; Antibodies, Monoclonal; Antigen-Antibody Complex; Antigens, Surface; Avidin; Biotin; Carcinoma, Transitional Cell; Humans; Immunoenzyme Techniques; Isoantigens; Neoplasm Staging; Urinary Bladder Neoplasms | 1992 |
Analyses of avidin-biotin complexes with lectins of membrane glycoproteins in the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Avidin; Biotin; Butylhydroxybutylnitrosamine; Glycoproteins; Lectins; Male; Membrane Proteins; Nitrosamines; Rats; Rats, Inbred F344; Staining and Labeling; Urinary Bladder Neoplasms | 1987 |
HRAS1-selected, chromosome mediated gene transfer; in situ hybridization with combined biotin and tritium label localizes the oncogene and reveals duplications of the human transgenome.
Topics: Animals; Biotin; Cell Line; Chromosome Mapping; Chromosomes, Human, Pair 11; Genetic Markers; Humans; Karyotyping; Mice; Multigene Family; Nucleic Acid Hybridization; Oncogenes; Transformation, Genetic; Tritium; Urinary Bladder Neoplasms | 1987 |
Development of an avidin-biotin amplified enzyme-linked immunoassay for detection of DNA adducts of the human bladder carcinogen 4-aminobiphenyl.
Topics: Aminobiphenyl Compounds; Avidin; Binding, Competitive; Biotin; Carcinogens; Cross Reactions; DNA; Enzyme-Linked Immunosorbent Assay; Humans; Urinary Bladder Neoplasms | 1986 |
Preliminary results on the use of the humoral immune response as a serum marker in patients with bladder tumors.
Topics: Antibody Formation; Avidin; Biotin; Cell Line; Humans; Methods; Prospective Studies; Spectrophotometry; Urinary Bladder Neoplasms | 1985 |